Clinical Trials Unit

HALT-IT trial found that TXA does NOT reduce deaths from stomach bleeding but increases the risk of thromboembolic events (deep vein thrombosis or pulmonary embolism)

Details

The CRASH-3 Trial shows that TXA as the world first drug for TBI

The CRASH-3 Results and News

October 15, 2019 Clinical Trials,LSHTM CTU News,Tranexamic Acid (TXA),Trauma Care CTU admin

Tranexamic Acid (TXA) is a safe, low cost, and widely available drug which could prevent deaths from TBI by as much as 20% depending on severity of the injury

Details

ISTH TV on Tranexamic Acid: The importance of giving TXA early to trauma and PPH patients

ISTH TV: The importance of giving TXA early to trauma & PPH patients

July 10, 2019 LSHTM CTU News,Tranexamic Acid (TXA) CTU admin

Watch Prof Ian Roberts on International Society on Thrombosis and Hemostasis Daily News, discussing the importance of giving TXA early to trauma & PPH patients

Details

Clinical trial managers need recognition for their work

June 13, 2019 Clinical Trials,Trial Management CTU admin

Expert trial managers with the training and experience to overcome operational challenges are often the difference between the success and failure of a clinical trial.

Details

WOMAN Trial shows TXA reduces premature death for PPH patients

WOMAN Trial Results and News

April 26, 2017 Clinical Trials,Emergency Care,LSHTM CTU News,Maternal Health,Tranexamic Acid (TXA) CTU admin

Can we prevent women from dying after childbirth? The WOMAN trial showed that if given within 3 hours, TXA can reduce the risk of death due to bleeding by one third.

Details

TXA should be given as early as possible to bleeding trauma patients

The CRASH-2 Results and News

June 14, 2010 Clinical Trials,Emergency Care,LSHTM CTU News,Tranexamic Acid (TXA) CTU admin

Global trial CRASH-2 is now complete and shows new hopes to cut deaths from serious injury – a simple jab of Tranexamic Acid could save up to 100,000 lives a year.

Details